Regulatory effect of hydrogen sulfide on vascular collagen content in spontaneously hypertensive rats

Hypertension Research

Volumn 31, Issue 8, 2008, Pages 1619-1630

  Zhao, Xia ^a   Zhang, Li Ke ^b   Zhang, Chun Yu ^a   Zeng, Xiang Jun ^b   Yan, Hui ^a   Jin, Hong Fang ^a   Tang, Chao Shu ^a,c   Du, Jun Bao ^a,c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Collagen; Hydrogen sulfide; Hypertension; Spontaneously hypertensive rat; Vascular remodeling

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; COLLAGEN TYPE 1; DIHYDRALAZINE; HYDROGEN SULFIDE; HYDROXYPROLINE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BINDING AFFINITY; BLOOD PRESSURE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVATION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; SPONTANEOUSLY HYPERTENSIVE RAT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT;

EID: 55449104752     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1619     Document Type: Article

References (40)

1. Sasamura H, Shimizu-Hirota R, Saruta T: Extracellular matrix remodeling in hypertension. Curr Hypertens Rev 2005; 1: 51-60.
2. ω-nitro-L-arginine methyl ester in mice. Hypertens Res 2007; 30: 563-571.
3. Sasaki R, Yamano S, Yamamoto Y, et al: Vascular remodeling of the carotid artery in patients with untreated essential hypertension increases with age. Hypertens Res 2002; 25: 373-379.
4. Du JB, Yan H, Wei B, Li J, Qi JG, Tang CS: Effect of L-arginine on collagen of high flow-induced pulmonary arterial remodeling. Circ J 2005; 69: 603-608.
5. Ishikawa J, Kario K, Matsui Y, et al: Collagen metabolism in extracellular matrix may be involved in arterial stiffness in older hypertensive patients with left ventricular hypertrophy. Hypertens Res 2005; 28: 995-1001.
6. Brassard P, Amiri F, Schiffrin EL: Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries. Hypertension 2005; 46: 598-606.
7. Brilla CG, Janicki JS, Weber KT: Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991; 83: 1771-1779.
8. Varo N, Etayo JC, Zalba G, et al: Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats. J Hypertens 1999; 17: 107-114.
9. Gompf H, Luft FC, Morano I: Nitric oxide synthase upregulation and the predelivery blood pressure decrease in spontaneously hypertensive rats. J Hypertens 2002; 20: 255-261.
10. Hampl V, Bibova J, Banasova A, et al: Pulmonary vascular iNOS induction participates in the onset of chronic hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2006; 290: L11-L20.
11. Somaza B, González C, Cachofeiro V, Lahera V, Fernández-Alfonso MS: Chronic L-arginine treatment reduces vascular smooth muscle cell hypertrophy through cell cycle modification in spontaneously hypertensive rats. J Hypertens 2004; 22: 751-758.
12. Morita T, Mitsialis SA, Koike H, Liu YX, Kourembanas S: Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 1997; 272: 32804-32809.
13. Shi Y, Du JB, Gong LM, Zeng CM, Tang XY, Tang CS: The regulating effect of heme oxygenase/carbon monoxide on hypoxic pulmonary vascular structural remodeling. Biochem Biophys Res Commun 2003; 306: 523-529.
14. Wei B, Du JB, Cong BL: Study of reversing effect of nitric oxide precursor on collagen accumulation in pulmonary artery. Chin Pharm 2003; 14: 653-654.
15. Gong LM, Du JB, Shi L, Shi Y, Tang CS: Effects of endogenous carbon monoxide on collagen synthesis in pulmonary artery in rats under hypoxia. Life Sci 2004; 74: 1225-1241.
16. Stipanuk MH: Beck PW: Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J 1982; 206: 267-277.
17. Hosoki R, Matsuki N, Kimura H: The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237: 527-531.
18. (ATP) channel opener. EMBO J 2001; 20: 6008-6016.
19. Zhang CY, Du JB, Bu DF, Yan H, Tang XY, Tang CS: The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 2003; 302: 810-816.
20. Li XH, Du JB, Bu DF, Tang XY, Tang CS: Sodium hydrosulfide alleviated pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Acta Pharmacol Sin 2006; 27: 977-986.
21. 2S) content during septic shock and endptoxin shock in rats. J Infect 2003, 47: 155-160.
22. Yan H, Du JB, Tang CS: The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 2004; 313: 22-27.
23. Zhong GZ, Chen FG, Cheng YQ, Tang CS, Du JB: The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 2003; 21: 1879-1885.
24. Zhang CY, Du JB, Yan H, Tang CS: Effect of a new gasotransmitter, hydrogen sulfide, on collagen remodeling of pulmonary artery under hypoxia. Zhonghua Jie He He Hu Xi Za Zhi 2005; 28: 448-452.
25. Li YL: Encyclopedia of Chinese Laboratory Investigation. Beijing, The People's Publishing Company of Health, 1996, 692 pp.
26. Hirata Y, Taragi Y, Takata S: CGRP receptor in cultured vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun 1988; 151: 1113-1118.
27. Diegelmann RF, Bryson GR, Flood LC, Graham MF: A microassay to quantitate collagen synthesis by cells in culture. Anal Biochem 1990; 186: 293-300.
28. 3H-proline-labeled protein by rapid filtration in multiwell plates for the study of collagen metabolism. Biotechniques 1997; 22: 706-708.
29. Du JB, Chen XB, Geng B, Jiang HF, Tang CS: Hydrogen sulfide as a messenger molecule in cardiovascular system. J Peking Univ (Health Sci) 2002; 34: 187.
30. Schiffrin EL, Park JB, Intengan H, Touyz RM: Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin II receptor antagonist losartan. Circulation 2000; 101: 1653-1659.
31. Kubo M, Umemoto S, Fujii K, et al: Effects of angiotensin II type 1 receptor antagonist on smooth muscle cell phenotype in intramyocardial arteries from spontaneously hypertensive rats. Hypertens Res 2004; 27: 685-693.
32. Yao L, Kobori H, Rahman M, et al: Olmesartan improves endothelin-induced hypertension and oxidative stress in rats. Hypertens Res 2005; 27: 493-500.
33. Touyz RM, El Mabrouk M, Schiffrin EL: Mitogen-activated protein/ extracellular signal-regulated kinase inhibition attenuates Ang II-mediated signaling and contraction in SHR vascular smooth muscle cells. Circ Res 1999; 84: 505-515.
34. Touyz RM, He G, El Mabrouk M, Schiffrin EL: p38 MAP kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY. Hypertension 2001; 37: 574.
35. Viedt C, Soto U, Krieger-Brauer HI, et al: Differential activation of MAP kinases in smooth muscle cells by Ang II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 2000; 20: 940-948.
36. Touyz RM, Schiffrin EL: Ang II-induced superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 1999; 34: 976-982.
37. Touyz RM, He G, El Mabrouk M, Diep Q, Mardigyan V, Schiffrin EL: Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats. J Hypertens 2001; 19: 553-559.
38. De Godoy MA, Rattan S: Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats. J Pharmacol Exp Ther 2006; 318: 725-734.
39. Du JB, Yan H, Cheung YF, et al: The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 2004; 19: 75-80.
40. 2S on human aorta smooth muscle cells. FASEB J 2006; 20: 553-555.